Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Eisai claims UK grant to expand manufacturing site
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

pharminent June 15, 2026 (Last updated: June 15, 2026)

Pharmaphorum

Eisai has been given a grant from the UK that will support a 48m plan to add cold chain capabilities to its facility in Hatfield, Hertfordshire.

Read full story

Post navigation

Previous: Key pipeline drug for Lundbeck delivers in Cushing syndrome
Next: FDA and MHRA forge new regulatory collaboration initiative

Related Stories

  • Manufacturing

BMS banks on Texas for $2.3bn multi-modal manufacturing facility

pharminent August 11, 2026
  • Manufacturing

AsymBio to secure $184m to support growth in biologics manufacturing

pharminent August 5, 2026
  • Manufacturing

Lilly and Resilience invest $750M in diabetes and obesity drug device supply

pharminent July 31, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.